Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier
Open accessAbstract
AIM: To investigate whether gut microbiota metabolite sodium butyrate (NaB) is an effective substance for attenuating non-alcoholic fatty liver disease (NAFLD) and the internal mechanisms. METHODS: Male C57BL/6J mice were divided into three groups, normal control were fed standard chow and model group were fed a high-fat diet (HFD) for 16 wk, the intervention group were fed HFD for 16 wk and treated with NaB for 8 wk. Gut microbiota from each group were detected at baseline and at 16 wk, liver histology were evaluated and gastrointestinal barrier indicator such as zonula occluden-1 (ZO-1) were detected by immunohistochemistry and realtime-PCR, further serum or liver endotoxin were determined by ELISA and inflammation- or metabolism-associated genes were quantified by real-time PCR. RESULTS: . These bacteria can produce butyric acid in what seems like a virtuous circle. And butyrate restored HFD induced intestinal mucosa damage, increased the expression of ZO-1 in small intestine, further decreased the levels of gut endotoxin in serum and liver compared with HF group. Endotoxin-associated genes such as TLR4 and Myd88, pro-inflammation genes such as MCP-1, TNF-α, IL-1, IL-2, IL-6 and IFN-γ in liver or epididymal fat were obviously downregulated after NaB intervention. Liver inflammation and fat accumulation were ameliorated, the levels of TG and cholesterol in liver were decreased after NaB intervention, NAS score was significantly decreased, metabolic indices such as FBG and HOMA-IR and liver function indicators ALT and AST were improved compared with HF group. CONCLUSION: NaB may restore the dysbiosis of gut microbiota to attenuate steatohepatitis, which is suggested to be a potential gut microbiota modulator and therapeutic substance for NAFLD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
NaB reduced the entry of inflammatory factors into the liver by regulating gut microbial dysbiosis, thereby reducing steatohepatitis induced by a high-fat diet.
“Zhou et al. reported that sodium butyrate (NaB) reduced the entry of inflammatory factors into the liver by regulating gut microbial dysbiosis, thereby reducing steatohepatitis induced by a high-fat diet [21].”
From Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease (2023) · cites this paper as [21]
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 20,966 · see citing works
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781 · see citing works
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762 · see citing works
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · see citing works
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048 · see citing works
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662 · see citing works
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · see citing works
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · see citing works
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681 · see citing works
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164 · see citing works
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · see citing works
The gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791 · see citing works
Microbiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457 · see citing works
Nonalcoholic Fatty Liver Disease
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,289 · see citing works
Butyrate improves insulin sensitivity and increases energy expenditure in mice
Gao, Z., Yin, J., Zhang, J., Ward, R. E., Martin, R. J., Lefevre, M., Cefalu, W. T., & Ye, J. (2009) · Diabetes · doi:10.2337/db08-1637 · Cited by 2,204 · see citing works
Rivière, A., Selak, M., Lantin, D., Leroy, F., & Vuyst, L. D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00979 · Cited by 1,746 · see citing works
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483 · see citing works
Chambers, E. S., Viardot, A., Psichas, A., Morrison, D. J., Murphy, K. G., Zac-Varghese, S. E. K., MacDougall, K., Preston, T., Tedford, C., Finlayson, G. S., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307913 · Cited by 1,424 · see citing works
Park, J., Kim, M., Kang, S. G., Jannasch, A. H., Cooper, B., Patterson, J., & Kim, C. H. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.44 · Cited by 1,307 · see citing works
The global burden of liver disease: The major impact of China
Wang, F., Fan, J., Zhang, Z., Gao, B., & Wang, H. (2014) · Hepatology · doi:10.1002/hep.27406 · Cited by 1,258 · see citing works
Self-citationGut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects
Radilla-Vázquez, R. B., Parra‐Rojas, I., Martínez-Hernández, N. E., Márquez‐Sandoval, F., Illades‐Aguiar, B., & Castro-Alarcón, N. (2016) · Obesity Facts · doi:10.1159/000442479 · Cited by 1,200 · see citing works
Minireview: Gut microbiota: The neglected endocrine organ
Clarke, G., Stilling, R. M., Kennedy, P. J., Stanton, C., Cryan, J. F., & Dinan, T. G. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1108 · Cited by 1,192 · see citing works
Wang, Y., Sheng, H.-F., He, Y., Wu, J.-Y., Jiang, Y., Tam, N. F. Y., & Zhou, H. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.01821-12 · Cited by 894 · see citing works
Wang, J., Tang, H., Zhang, C., Zhao, Y., Derrien, M., Rocher, E., Vlieg, J. E. V. H., Strissel, K. J., Zhao, L., Obin, M. S., et al. (2014) · The ISME Journal · doi:10.1038/ismej.2014.99 · Cited by 833 · see citing works
From the gut to the peripheral tissues: the multiple effects of butyrate
Guilloteau, P., Martin, L., Eeckhaut, V., Ducatelle, R., Zabielski, R., & Immerseel, F. V. (2010) · Nutrition Research Reviews · doi:10.1017/s0954422410000247 · Cited by 813 · see citing works
Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation
Kim, C. H., Park, J., & Kim, M. (2014) · Immune Network · doi:10.4110/in.2014.14.6.277 · Cited by 704 · see citing works
Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., Greenwood, R., Sikaroodi, M., Lam, V., Crotty, P., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.015 · Cited by 672 · see citing works
Insights into the role of the microbiome in obesity and type 2 diabetes
Hartstra, A. V., Bouter, K. E. C., Bäckhed, F., & Nieuwdorp, M. (2015) · Diabetes Care · doi:10.2337/dc14-0769 · Cited by 641 · see citing works
Canani, R. B., Sangwan, N., Stefka, A. T., Nocerino, R., Paparo, L., Aitoro, R., Calignano, A., Khan, A. A., Gilbert, J. A., & Nagler‐Anderson, C. (2015) · The ISME Journal · doi:10.1038/ismej.2015.151 · Cited by 525 · see citing works
Rivas, M. N., Burton, O. T., Wise, P. M., Zhang, Y., Hobson, S. A., Lloret, M. G., Chehoud, C., Kuczynski, J., DeSantis, T. Z., Warrington, J. A., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.10.026 · Cited by 488 · see citing works
Zhang, J., Guo, Z., Xue, Z., Sun, Z., Zhang, M., Wang, L., Wang, G., Wang, F., Xu, J., Cao, H., et al. (2015) · The ISME Journal · doi:10.1038/ismej.2015.11 · Cited by 459 · see citing works
Self-citationMicrobial butyrate and its role for barrier function in the gastrointestinal tract
Plöger, S., Stumpff, F., Penner, G. B., Schulzke, J., Gäbel, G., Märtens, H., Shen, Z., Günzel, D., & Aschenbach, J. R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06553.x · Cited by 445 · see citing works
Role of the Microbiome in Energy Regulation and Metabolism
Nieuwdorp, M., Gilijamse, P. W., Pai, N., & Kaplan, L. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.008 · Cited by 421 · see citing works
Jiang, X.-T., Peng, X., Deng, G.-H., Sheng, H., Wang, Y., Zhou, H.-W., & Tam, N. (2013) · Microbial Ecology · doi:10.1007/s00248-013-0238-8 · Cited by 366 · see citing works
Leonel, A. J., & Alvarez-Leite, J. I. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32835665fa · Cited by 362 · see citing works
Zhang, G.-L., & Ghosh, S. (2000) · Journal of Endotoxin Research · doi:10.1179/096805100101532414 · Cited by 307 · see citing works
SCFAs Induce Mouse Neutrophil Chemotaxis through the GPR43 Receptor
Vinolo, M. A. R., Ferguson, G. J., Kulkarni, S., Damoulakis, G., Anderson, K. E., Bohlooly‐Y, M., Stephens, L., Hawkins, P. T., & Curi, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021205 · Cited by 292 · see citing works
Gastaldelli, A., Harrison, S. A., Belfort-Aguilar, R., Hardies, L. J., Balas, B., Schenker, S., & Cusi, K. (2009) · Hepatology · doi:10.1002/hep.23116 · Cited by 285 · see citing works
Park, J.-S., Lee, E.-J., Lee, J.-C., Kim, W.-K., & Kim, H.-S. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2006.08.015 · Cited by 278 · see citing works
Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010
Fan, J., Jia, J. D., Li, Y. M., Wang, B. Y., Lu, L., Shi, J., & Chan, L.-Y. (2010) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2010.00476.x · Cited by 277 · see citing works
Self-citationMILLARD, A. L., MERTES, P. M., ITTELET, D., VILLARD, F., JEANNESSON, P., & BERNARD, J. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.0009-9104.2002.01977.x · Cited by 220 · see citing works
Guidelines for the diagnosis and management of alcoholic liver disease: Update 2010
Li, Y. M., Fan, J., Wang, B. Y., Lu, L., Shi, J., Niu, J. Q., & Wei, S. H. E. N. (2010) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2010.00477.x · Cited by 219 · see citing works
Self-citationRaso, G. M., Simeoli, R., Russo, R., Iacono, A., Santoro, A. N., Paciello, O., Ferrante, M. C., Canani, R. B., Calignano, A., & Meli, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068626 · Cited by 196 · see citing works
Sodium butyrate maintains growth performance by regulating the immune response in broiler chickens
Zhang, W. H., Jiang, Y., Zhu, Q., Gao, F., Dai, S., Chen, J., & Zhou, G. (2011) · British Poultry Science · doi:10.1080/00071668.2011.578121 · Cited by 188 · see citing works
Henagan, T. M., Stefañska, B., Fang, Z., Navard, A. M., Ye, J., Lenard, N. R., & Devarshi, P. P. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13058 · Cited by 172 · see citing works
Histone Deacetylase Inhibitors Up-Regulate the Expression of Tight Junction Proteins
Bordin, M., D'Atri, F., Guillemot, L., & Citi, S. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.692.2.12 · Cited by 168 · see citing works
Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota
Mishra, A. K., Dubey, V., & Ghosh, A. R. (2016) · Metabolism · doi:10.1016/j.metabol.2015.10.008 · Cited by 161 · see citing works
Jin, C. J., Sellmann, C., Engstler, A. J., Ziegenhardt, D., & Bergheim, I. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515003621 · Cited by 130 · see citing works
Yan, H., & Ajuwon, K. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145940 · Cited by 90 · see citing works
Stenman, L. K., Burcelin, R., & Lahtinen, S. J. (2015) · Beneficial Microbes · doi:10.3920/bm2015.0069 · Cited by 78 · see citing works
Gut microbiota and non-alcoholic fatty liver disease
Gkolfakis, P., Dimitriadis, G., & Τriantafyllou, Κ. (2015) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(15)60026-1 · Cited by 78 · see citing works
Kumar, A., Alrefai, W. A., Borthakur, A., & Dudeja, P. K. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00186.2015 · Cited by 72 · see citing works
Fernando, M., Saxena, A., Reyes, J. L., & McKay, D. M. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00440.2015 · Cited by 67 · see citing works
The Role of Probiotics on the Microbiota
Nova, E., de Heredia, F. P., Gómez‐Martínez, S., & Marcos, A. (2016) · Nutrition in Clinical Practice · doi:10.1177/0884533615620350 · Cited by 65 · see citing works
Gut microbiota and non-alcoholic fatty liver disease
Paraskevas, Gkolfakis, George, Dimitriadis, Κωνσταντίνος, & Triantafyllou (2015) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 47 · see citing works
Lu, J., Wen, Z., & Zou, X. (2012) · Journal of Animal and Veterinary Advances · doi:10.3923/javaa.2012.814.821 · Cited by 30 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Short chain fatty acids in human gut and metabolic health
Blaak, E. E., Canfora, E. E., Theis, S., Frost, G., Groen, A. K., Mithieux, G., Nauta, A., Scott, K., Stahl, B., van Harsselaar, J., et al. (2020) · Beneficial Microbes · doi:10.3920/bm2020.0057 · Cited by 1,103 · see citing works
Short-chain fatty acids in diseases
Zhang, D., Jian, Y., Zhang, Y., Li, Y., Gu, L.-T., Sun, H.-H., Liu, M., Zhou, H., Wang, Y., & Xu, Z. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01219-9 · Cited by 763 · see citing works
Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health
Chambers, E. S., Preston, T., Frost, G., & Morrison, D. J. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0248-8 · Cited by 691 · see citing works
The role of the microbiome in NAFLD and NASH
Kolodziejczyk, A. A., Zheng, D., Shibolet, O., & Elinav, E. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809302 · Cited by 523 · see citing works
Li, H., Zhou, D.-D., Gan, R., Huang, S., Zhao, C., Shang, A., Xu, X., & Li, H. (2021) · Nutrients · doi:10.3390/nu13093211 · Cited by 514 · see citing works
Self-citationContribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Chopyk, D. M., & Grakoui, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.077 · Cited by 495 · see citing works
Role of the gut microbiota in type 2 diabetes and related diseases
Yang, G., Wei, J., Liu, P., Zhang, Q., Tian, Y., Hou, G., Meng, L., Xin, Y., & Jiang, X. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154712 · Cited by 418 · see citing works
The Role of Short Chain Fatty Acids in Inflammation and Body Health
Du, Y., He, C., An, Y., Huang, Y., Zhang, H., Fu, W., Wang, M., Shan, Z., Xie, J., Yang, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137379 · Cited by 411 · see citing works
Self-citationFacchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., Barba, C. D., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 422 · see citing works
Xu, X., Poulsen, K. L., Wu, L., Liu, S., Miyata, T., Song, Q., Wei, Q., Zhao, C., Lin, C., & Yang, J. B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01119-3 · Cited by 370 · see citing works
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Chen, J., & Vitetta, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155214 · Cited by 357 · see citing works
Zhao, Z., Xin, F., Xue, Y., Hu, Z., Han, Y., Ma, F., Zhou, D., Liu, X., Cui, A., Liu, Z., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0304-5 · Cited by 353 · see citing works
Self-citationLean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation
Chen, F., Esmaili, S., Rogers, G. B., Bugianesi, E., Petta, S., Marchesini, G., Bayoumi, A., Metwally, M., Azardaryany, M. K., Coulter, S., et al. (2019) · Hepatology · doi:10.1002/hep.30908 · Cited by 330 · see citing works
Biological Function of Short-Chain Fatty Acids and Its Regulation on Intestinal Health of Poultry
Liu, L., Li, Q., Yang, Y., & Guo, A. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.736739 · Cited by 318 · see citing works
Li, J.-M., Yu, R., Zhang, L.-P., Wen, S.-Y., Wang, S.-J., Zhang, X.-Y., Xu, Q., & Kong, L.-D. (2019) · Microbiome · doi:10.1186/s40168-019-0713-7 · Cited by 300 · see citing works
Kang, C., Wang, B., Kaliannan, K., Wang, X., Lang, H., Hui, S., Huang, L., Zhang, Y., Zhou, M., Chen, M., et al. (2017) · mBio · doi:10.1128/mbio.00470-17 · Cited by 273 · see citing works
The Protective Role of Butyrate against Obesity and Obesity-Related Diseases
Coppola, S., Avagliano, C., Calignano, A., & Canani, R. B. (2021) · Molecules · doi:10.3390/molecules26030682 · Cited by 267 · see citing works
Lactobacillus and intestinal diseases: Mechanisms of action and clinical applications
Huang, R., Wu, F. L., Zhou, Q., Wei, W., Juan, Y., Xiao, B., & Luo, Z. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127019 · Cited by 258 · see citing works
Role of gut microbiota on intestinal barrier function in acute pancreatitis
Li, X.-Y., He, C., Zhu, Y., & Lü, N. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i18.2187 · Cited by 251 · see citing works
Self-citationJi, Y. S., Yin, Y., Li, Z., & Zhang, W. (2019) · Nutrients · doi:10.3390/nu11081712 · Cited by 230 · see citing works
Zhou, D., Chen, Y., Zhao, Z., Yang, R., Xin, F., Liu, X., Pan, Q., Zhou, H., & Fan, J. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0183-1 · Cited by 218 · see citing works
Self-citationBeisner, J., Rosa, L. F., Kaden-Volynets, V., Stolzer, I., Günther, C., & Bischoff, S. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678360 · Cited by 215 · see citing works
Ye, J., Lv, L., Wu, W., Li, Y., Shi, D., Fang, D., Guo, F., Jiang, H., Ren, Y., Ye, W., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01967 · Cited by 211 · see citing works
Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy
Ma, J., Zhou, Q., & Li, H. (2017) · Nutrients · doi:10.3390/nu9101124 · Cited by 197 · see citing works
Lambertz, J., Weiskirchen, S., Landert, S., & Weiskirchen, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01159 · Cited by 184 · see citing works
Metformin attenuated sepsis-related liver injury by modulating gut microbiota
Liang, H., Song, H., Zhang, X., Song, G., Wang, Y., Ding, X., Duan, X., Li, L., Sun, T., & Kan, Q. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2045876 · Cited by 175 · see citing works
Comparison of Fecal Collection Methods for Microbiome and Metabolomics Studies
Wang, Z., Zolnik, C. P., Qiu, Y., Usyk, M., Wang, T., Strickler, H. D., Isasi, C. R., Kaplan, R. C., Kurland, I. J., Qi, Q., et al. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00301 · Cited by 166 · see citing works
Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
Iacob, S. A., & Iacob, D. G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01676 · Cited by 152 · see citing works
van Deuren, T., Blaak, E. E., & Canfora, E. E. (2022) · Obesity Reviews · doi:10.1111/obr.13498 · Cited by 162 · see citing works
Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22–dependent manner
Busbee, P. B., Menzel, L. P., Alrafas, H. R., Dopkins, N., Becker, W., Miranda, K., Tang, C., Chatterjee, S., Singh, U. P., Nagarkatti, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.127551 · Cited by 153 · see citing works
Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders
Maioli, T. U., Nogués, E. B., Torres, L., Barbosa, S. C., Martins, V. D., Langella, P., Azevedo, V., & Chatel, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.740636 · Cited by 151 · see citing works
Lange, O., Proczko-Stepaniak, M., & Mika, A. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00503-6 · Cited by 155 · see citing works
Tang, W., Yao, X., Xia, F., Yang, M., Chen, Z., Zhou, B., & Liu, Q. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7261619 · Cited by 148 · see citing works
Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease
Couto, M. R., Gonçalves, P., Magro, F., & Martel, F. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104947 · Cited by 148 · see citing works
Chen, M., Hou, P., Zhou, M., Ren, Q., Wang, X., Huang, L., Hui, S., Yi, L., & Mi, M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.05.020 · Cited by 148 · see citing works
Qiao, S., Li, B., Wang, K., Sun, S., Liao, M., Liu, C., Zhou, N., Ma, K., Zhang, Y., Chen, Y., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108005 · Cited by 147 · see citing works
Self-citationWu, W., Xiao, Z., An, W., Dong, Y., & Zhang, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197762 · Cited by 146 · see citing works
The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
Song, Q., & Zhang, X. (2022) · Biomedicines · doi:10.3390/biomedicines10030524 · Cited by 147 · see citing works
Zhou, W., Yang, T., Xu, W., Huang, Y., Ran, L., Yan, Y., Mi, J., Lu, L., Sun, Y., Zeng, X., et al. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119626 · Cited by 148 · see citing works
Meroni, M., Longo, M., & Dongiovanni, P. (2019) · Nutrients · doi:10.3390/nu11112642 · Cited by 146 · see citing works
Butyrate as a bioactive human milk protective component against food allergy
Paparo, L., Nocerino, R., Ciaglia, E., Scala, C. D., Caro, C. D., Russo, R., Trinchese, G., Aitoro, R., Amoroso, A., Bruno, C., et al. (2020) · Allergy · doi:10.1111/all.14625 · Cited by 140 · see citing works
Mitotherapy for Fatty Liver by Intravenous Administration of Exogenous Mitochondria in Male Mice
Fu, A., Shi, X., Zhang, H., & Fu, B. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00241 · Cited by 139 · see citing works
Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
Han, H. L., Jiang, Y., Wang, M., Melaku, M., Liu, L., Zhao, Y. M., Everaert, N., Yi, B., & Zhang, H. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1966738 · Cited by 130 · see citing works
Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota
Loke, Y. L., Chew, M. T., Ngeow, Y. F., Lim, W. W.-D., & Peh, S. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.603086 · Cited by 129 · see citing works
Chen, H., Qian, Y., Jiang, C., Tang, L., Yu, J., Zhang, L., Dai, Y., & Jiang, G. Z. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166984 · Cited by 127 · see citing works
Khan, A., Ding, Z., Ishaq, M. H., Bacha, A. S., KHAN, I. A., Hanif, A., Li, W., & Guo, X. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56214 · Cited by 126 · see citing works
Gao, X., Chang, S., Liu, S., Peng, L., Xie, J., Dong, W., Tian, Y., & Sheng, J. (2020) · mSystems · doi:10.1128/msystems.00391-20 · Cited by 120 · see citing works
Zhao, Z., Wang, Z., Zhou, D., Han, Y., Ma, F., Hu, Z., Xin, F., Liu, X., Ren, T., Zhang, F., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.05.006 · Cited by 112 · see citing works
Self-citationLiu, W., Luo, X., Tang, J., Mo, Q., Zhong, H., Zhang, H., & Feng, F. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02431-w · Cited by 111 · see citing works
Sun, B., Jia, Y., Hong, J., Sun, Q., Gao, S., Hu, Y., Zhao, N., & Zhao, R. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01189 · Cited by 106 · see citing works
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy
Zhang, Y., Xiao, Z., Yu, X., Novák, P., Gui, Q., & Yin, K. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1120168 · Cited by 110 · see citing works
Dietary butyrate suppresses inflammation through modulating gut microbiota in high-fat diet-fed mice
Zhai, S., Qin, S., Li, L., Zhu, L., Zou, Z., & Wang, L. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz153 · Cited by 101 · see citing works
Li, J., Fang, B., Pang, G., Zhang, M., & Ren, F. (2019) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2019.05.018 · Cited by 104 · see citing works
Whole food-based approaches to modulating gut microbiota and associated diseases
Han, Y., & Xiao, H. (2020) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-111519-014337 · Cited by 101 · see citing works
Ding, Q., Cao, F., Lai, S., Zhuge, H., Chang, K., Valencak, T. G., Liu, J., Li, S., & Ren, D. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111259 · Cited by 101 · see citing works
Sodium butyrate in both prevention and supportive treatment of colorectal cancer
Kaźmierczak-Siedlecka, K., Marano, L., Merola, E., Roviello, F., & Połom, K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1023806 · Cited by 106 · see citing works
Microbial Metabolites: Critical Regulators in NAFLD
Dai, X., Hou, H., Zhang, W., Liu, T., Li, Y., Wang, S., Wang, B., & Cao, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.567654 · Cited by 102 · see citing works
Capsaicin and Gut Microbiota in Health and Disease
Roşca, A. E., Ieșanu, M. I., Zahiu, C. D. M., Voiculescu, S. E., Paslaru, A. C., & Zăgrean, A. (2020) · Molecules · doi:10.3390/molecules25235681 · Cited by 102 · see citing works
Horvath, A., Leber, B., Feldbacher, N., Tripolt, N. J., Rainer, F., Blesl, A., Trieb, M., Marsche, G., Sourij, H., & Stadlbauer, V. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02135-w · Cited by 99 · see citing works
Microbial metabolites in non-alcoholic fatty liver disease
Zhou, D., & Fan, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i17.2019 · Cited by 94 · see citing works
Self-citationLiraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db/db mice
Liu, Q., Cai, B.-Y., Zhu, L., Xin, X., Wang, X., An, Z., Li, S., Hu, Y., & Feng, Q. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118457 · Cited by 92 · see citing works
Overview of the Importance of Biotics in Gut Barrier Integrity
Kocot, A. M., Jarocka‐Cyrta, E., & Drabińska, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052896 · Cited by 95 · see citing works
Zhong, Y., Wang, T., Luo, R., Liu, J., Jin, R., & Peng, X. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2158174 · Cited by 96 · see citing works
The Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity
You, H., Tan, Y., Yu, D., Qiu, S., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.886902 · Cited by 93 · see citing works
Chen, M., Hui, S., Lang, H., Zhou, M., Zhang, Y., Kang, C., Zeng, X., Zhang, Q., Yi, L., & Mi, M. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800612 · Cited by 85 · see citing works
Dai, X., Guo, Z., Chen, D., Li, L., Song, X., Liu, T., Jin, G., Li, Y., Liu, Y., Ajiguli, A., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1738187 · Cited by 87 · see citing works
Wang, Q., Xu, K., Cai, X., Wang, C., Cao, Y., & Xiao, J. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c08444 · Cited by 87 · see citing works
Butyrate: A potential mediator of obesity and microbiome via different mechanisms of actions
Güler, M. S., Arslan, S., Ağagündüz, D., Cerqua, I., Pagano, E., Canani, R. B., & Capasso, R. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115420 · Cited by 87 · see citing works
Wang, G., Sun, S., Wu, X., Yang, S., Wu, Y., Zhao, J., Zhang, H., & Chen, W. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.110590 · Cited by 84 · see citing works
New insights in gut microbiota and mucosal immunity of the small intestine
Million, M., Tomas, J., Wagner, C., Lelouard, H., Raoult, D., & Gorvel, J. (2018) · Human Microbiome Journal · doi:10.1016/j.humic.2018.01.004 · Cited by 83 · see citing works
Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases
Hyun, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179139 · Cited by 84 · see citing works
Guo, T.-T., Zhang, Z., Sun, Y., Zhu, R.-Y., Wang, F.-X., Ma, L.-J., Jiang, L., & Liu, H.-D. (2023) · Nutrients · doi:10.3390/nu15040930 · Cited by 82 · see citing works
A double‐edged sword: Role of butyrate in the oral cavity and the gut
Guan, X., Li, W., & Meng, H. (2020) · Molecular Oral Microbiology · doi:10.1111/omi.12322 · Cited by 79 · see citing works
Butyrate prevents valproate‐induced liver injury: In vitro and in vivo evidence
Pirozzi, C., Lama, A., Annunziata, C., Cavaliere, G., Caro, C. D., Citraro, R., Russo, E., Tallarico, M., Iannone, M., Ferrante, M. C., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900927rr · Cited by 77 · see citing works
Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
Jiang, X., Zheng, J., Zhang, S., Wang, B., Wu, C., & Guo, X. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00361 · Cited by 79 · see citing works
Brown, K., Abbott, D., Uwiera, R., & Inglis, G. (2018) · Gut microbes · doi:10.1080/19490976.2017.1408763 · Cited by 66 · see citing works
Xin, F., Zhao, Z., Liu, X., Pan, Q., Wang, Z., Zeng, L., Zhang, Q., Ye, L., Wang, M., Zhang, R.-N., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.12.003 · Cited by 76 · see citing works
Self-citationButyrate and obesity: Current research status and future prospect
Peng, K., Dong, W., Luo, T., Tang, H., Zhu, W., Huang, Y., & Yang, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1098881 · Cited by 80 · see citing works
Miranda, C. L., Johnson, L. A., de Montgolfier, O., Elias, V. D., Ullrich, L. S., Hay, J. J., Paraiso, I. L., Choi, J., Reed, R. L., Revel, J. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18992-6 · Cited by 74 · see citing works
Peng, J., Leng, J., Tian, H., Yang, T., Fang, Y., Feng, Q., Zhao, Y., & Hu, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01399 · Cited by 75 · see citing works
Kundi, Z. M., Lee, J. C., Pihlajamäki, J., Chan, C. B., Leung, K. S., So, S. S. Y., Nordlund, E., Kolehmainen, M., & El-Nezami, H. S. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900580 · Cited by 74 · see citing works
High-Fat Diet Alters the Intestinal Microbiota in Streptozotocin-Induced Type 2 Diabetic Mice
Liu, S., Qin, P., & Wang, J. (2019) · Microorganisms · doi:10.3390/microorganisms7060176 · Cited by 77 · see citing works
Fecal Transplantation from db/db Mice Treated with Sodium Butyrate Attenuates Ischemic Stroke Injury
Wang, H., Song, W., Wu, Q., Gao, X., Li, J., Tan, C., Zhou, H., Zhu, J., He, Y., & Yin, J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00042-21 · Cited by 75 · see citing works
Pan, X., Kaminga, A. C., Liu, A., Wen, S. W., Luo, M., & Luo, J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.683743 · Cited by 68 · see citing works
Pohl, K., Moodley, P., & Dhanda, A. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15899 · Cited by 70 · see citing works
Liu, T., Sun, Z., Yang, Z., & Qiao, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114586 · Cited by 67 · see citing works
The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
Hliwa, A., Ramos‐Molina, B., Łaski, D., Mika, A., & Śledziński, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136900 · Cited by 66 · see citing works
Zhang, J., Zhong, L., Chi, S., Chu, W., Liu, Y., & Hu, Y. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.734952 · Cited by 66 · see citing works
Verdugo‐Meza, A., Ye, J., Dadlani, H., Ghosh, S., & Gibson, D. L. (2020) · Nutrients · doi:10.3390/nu12051434 · Cited by 69 · see citing works
Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota
Wisniewski, P. J., Dowden, R. A., & Campbell, S. C. (2019) · Nutrients · doi:10.3390/nu11010117 · Cited by 65 · see citing works
Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases
Asif, S., Morrow, N. M., Mulvihill, E. E., & Kim, K.-H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.590369 · Cited by 69 · see citing works
Zhao, T., Zhan, L., Zhou, W., Chen, W., Luo, J., Zhang, L., Weng, Z., Zhao, C., & Liu, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.647529 · Cited by 60 · see citing works
Zhao, Y., Sun, H., Chen, Y., Niu, Q., Dong, Y., Li, M., Yuan, Y., Yang, X., & Sun, Q. (2023) · mBio · doi:10.1128/mbio.01987-23 · Cited by 60 · see citing works
Self-citationShashni, B., Tajika, Y., Ikeda, Y., Nishikawa, Y., & Nagasaki, Y. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122047 · Cited by 59 · see citing works
Zhao, H., Gao, X., Liu, Z., Zhang, L., Fang, X., Sun, J., Zhang, Z., & Sun, Y. (2022) · Nutrients · doi:10.3390/nu14224846 · Cited by 58 · see citing works
Li, Y., Li, H., Wang, R., Yu, Y., Liu, X., & Tian, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114568 · Cited by 58 · see citing works
The Role of Intestinal Flora in the Regulation of Bone Homeostasis
Li, C., Pi, G., & Li, F. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.579323 · Cited by 57 · see citing works
Wang, K., Li, B., Zhou, N., Zhang, J., Liao, M., Zheng, Z., Wang, Y., Liu, C., Wang, J., Wang, L., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00107 · Cited by 57 · see citing works
Self-citationNon-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies
Leylabadlo, H. E., Ghotaslou, R., Kafil, H. S., Feizabadi, M. M., Moaddab, S. Y., Farajnia, S., Sheykhsaran, E., Sanaie, S., Shanehbandi, D., & Baghi, H. B. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03746-1 · Cited by 56 · see citing works
The Gut Microbial Endocrine Organ in Type 2 Diabetes
Massey, W. J., & Brown, J. M. (2020) · Endocrinology · doi:10.1210/endocr/bqaa235 · Cited by 61 · see citing works
- Authors
- Zhou, D., Pan, Q., Xin, F.-Z., Zhang, R.-N., He, C.-X., Chen, G.-Y., Liu, C., Chen, Y.-W., & Fan, J.-G.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2017
- Volume
- 23
- Issue
- 1
- Pages
- 60
- ISSN
- 1007-9327 (ISSN-L)
- PMC
- PMC5221287
- OpenAlex
- W2571212804
- Cited by
- 441
- References
- 56
- Citations by year
- 2026: 34 · 2025: 61 · 2024: 66 · 2023: 58 · 2022: 68 · 2021: 46 · 2020: 50 · 2019: 30 · 2018: 17 · 2017: 11
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Gastroenterology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- sodium butyrate, non-alcoholic fatty liver disease, steatohepatitis, high-fat diet, gut microbiota, intestinal barrier, zonula occludens-1, endotoxin, gut-liver axis, gut dysbiosis, inflammation, insulin resistance, butyrate
- MeSH terms
- Gastrointestinal Microbiome, Animals, Drug Evaluation, Preclinical, Humans, Immunohistochemistry, Inflammation, Intestinal Mucosa, Lactobacillus, Liver, Liver Function Tests, Male, Mice, Inbred C57BL, Specific Pathogen-Free Organisms, Tumor Necrosis Factor-alpha, Cytokines, Butyric Acid, Mice, Diet, High-Fat, Real-Time Polymerase Chain Reaction, Zonula Occludens-1 Protein, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review